| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2082095 | Drug Discovery Today: Disease Models | 2012 | 4 Pages |
Abstract
Recent advances in cellular reprogramming and stem cell biology have opened up unique opportunities in regenerative medicine, gene therapy and disease modeling. In this article, we will review these issues with particular reference to the impact of human induced pluripotent cell (hiPSC) technology in the modeling of human blood disorders.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Howard C.H. Chow, Alice M.S. Cheung, Ronald A. Li, Camie W.Y. Chan, Eric C.W. So, Anskar Y.H. Leung,